Risk factors and outcome of hyponatremia in patients with Guillain-Barré syndrome.
Autonomic dysfunction
Guillain–Barré syndrome
Hyponatremia
Outcome
Risk factors
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 Jul 2024
19 Jul 2024
Historique:
received:
14
01
2024
accepted:
11
07
2024
medline:
20
7
2024
pubmed:
20
7
2024
entrez:
19
7
2024
Statut:
epublish
Résumé
The objective of the present study was to evaluate the risk factors and outcomes associated with hyponatremia in patients with Guillain-Barré syndrome (GBS). We retrospectively studied 80 consecutive patients with GBS who visited our hospital and compared clinical, laboratory, and electrophysiological findings of patients with and without hyponatremia. Disability was evaluated using the Hughes grading system. Of the 80 patients, 18 (23%) had hyponatremia. Hyponatremia was significantly associated with older age (P = 0.003), urinary retention (P < 0.0001), Hughes grade ≥ 4 at admission and nadir (P = 0.003 and P < 0.001, respectively), acute inflammatory demyelinating polyneuropathy subtype (P = 0.017), sepsis (P = 0.001), mechanical ventilator support (P = 0.013), longer hospitalization length of stay (P < 0.0001), and inability to walk independently at 6 months (P < 0.001). Multivariate analysis performed to assess the risk factors of hyponatremia revealed that urinary retention (odds ratio [OR] 30.7, 95% confidence interval [CI] 3.6-264.4; P = 0.002) and mechanical ventilator support (OR 13.8, 95% CI 1.6-118.0; P = 0.017) were significant independent risk factors of hyponatremia. In assessing the outcomes of patients with hyponatremia, multivariate analysis showed that hyponatremia was independently associated with hospitalization length of stay ≥ 60 days and inability to walk independently at 6 month, with the former showing statistical significance but the latter not (OR 9.3, 95% CI 1.8-47.7; P = 0.007 and OR 4.9, 95% CI 0.9-26.3; P = 0.066, respectively). Therefore, we demonstrate that, along with mechanical ventilator support, urinary retention-possibly indicating autonomic dysfunction-is a risk factor of hyponatremia in GBS. Moreover, we confirm that hyponatremia is associated with poor outcome in GBS.
Identifiants
pubmed: 39030260
doi: 10.1038/s41598-024-67427-6
pii: 10.1038/s41598-024-67427-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16664Informations de copyright
© 2024. The Author(s).
Références
van Doorn, P. A., Ruts, L. & Jacobs, B. C. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 7, 939–950. https://doi.org/10.1016/S1474-4422(08)70215-1 (2008).
doi: 10.1016/S1474-4422(08)70215-1
pubmed: 18848313
Kaida, K. Guillain-Barre syndrome. Adv. Exp. Med. Biol. 1190, 323–331. https://doi.org/10.1007/978-981-32-9636-7_20 (2019).
doi: 10.1007/978-981-32-9636-7_20
pubmed: 31760653
Yuki, N. & Hartung, H. P. Guillain-Barre syndrome. N. Engl. J. Med. 366, 2294–2304. https://doi.org/10.1056/NEJMra1114525 (2012).
doi: 10.1056/NEJMra1114525
pubmed: 22694000
Kuwabara, S. & Yuki, N. Axonal Guillain-Barre syndrome: Concepts and controversies. Lancet Neurol. 12, 1180–1188. https://doi.org/10.1016/S1474-4422(13)70215-1 (2013).
doi: 10.1016/S1474-4422(13)70215-1
pubmed: 24229616
Kusunoki, S., Willison, H. J. & Jacobs, B. C. Antiglycolipid antibodies in Guillain-Barre and Fisher syndromes: Discovery, current status and future perspective. J. Neurol. Neurosurg. Psychiatry 92, 311–318. https://doi.org/10.1136/jnnp-2020-325053 (2021).
doi: 10.1136/jnnp-2020-325053
pubmed: 33376111
Saifudheen, K., Jose, J., Gafoor, V. A. & Musthafa, M. Guillain-Barre syndrome and SIADH. Neurology 76, 701–704. https://doi.org/10.1212/WNL.0b013e31820d8b40 (2011).
doi: 10.1212/WNL.0b013e31820d8b40
pubmed: 21339497
Hiew, F. L., Winer, J. B. & Rajabally, Y. A. Hyponatraemia in Guillain-Barre syndrome revisited. Acta Neurol. Scand. 133, 295–301. https://doi.org/10.1111/ane.12459 (2016).
doi: 10.1111/ane.12459
pubmed: 26184092
Rumalla, K., Reddy, A. Y., Letchuman, V. & Mittal, M. K. Hyponatremia in Guillain-Barre syndrome. J. Clin. Neuromuscul. Dis. 18, 207–217. https://doi.org/10.1097/CND.0000000000000157 (2017).
doi: 10.1097/CND.0000000000000157
pubmed: 28538251
Wang, Y. & Liu, J. Hyponatremia is a predictor for poor outcome in Guillain-Barre syndrome. Neurol. Res. 37, 347–351. https://doi.org/10.1179/1743132814Y.0000000455 (2015).
doi: 10.1179/1743132814Y.0000000455
pubmed: 25366666
Chakraborty, T., Kramer, C. L., Wijdicks, E. F. M. & Rabinstein, A. A. Dysautonomia in Guillain-Barre syndrome: Prevalence, clinical spectrum, and outcomes. Neurocrit. Care 32, 113–120. https://doi.org/10.1007/s12028-019-00781-w (2020).
doi: 10.1007/s12028-019-00781-w
pubmed: 31297663
Sipila, J. O., Kauko, T. & Soilu-Hanninen, M. Admission sodium level and prognosis in adult Guillain-Barre syndrome. Int. J. Neurosci. 127, 344–349. https://doi.org/10.3109/00207454.2016.1163551 (2017).
doi: 10.3109/00207454.2016.1163551
pubmed: 26971365
Gagliardi, D. et al. Sodium levels predict disability at discharge in Guillain-Barre syndrome: A retrospective cohort study. Front. Neurol. 12, 729252. https://doi.org/10.3389/fneur.2021.729252 (2021).
doi: 10.3389/fneur.2021.729252
pubmed: 34557155
pmcid: 8453067
Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann. Neurol. 27(Suppl), S21-24. https://doi.org/10.1002/ana.410270707 (1990).
doi: 10.1002/ana.410270707
pubmed: 2194422
Yuki, N. et al. Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes. J. Neurol. 259, 1181–1190. https://doi.org/10.1007/s00415-011-6330-4 (2012).
doi: 10.1007/s00415-011-6330-4
pubmed: 22143612
Uncini, A., Notturno, F. & Kuwabara, S. Hyper-reflexia in Guillain-Barre syndrome: Systematic review. J. Neurol. Neurosurg. Psychiatry 91, 278–284. https://doi.org/10.1136/jnnp-2019-321890 (2020).
doi: 10.1136/jnnp-2019-321890
pubmed: 31937584
Hughes, R. A., Newsom-Davis, J. M., Perkin, G. D. & Pierce, J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet 2, 750–753. https://doi.org/10.1016/s0140-6736(78)92644-2 (1978).
doi: 10.1016/s0140-6736(78)92644-2
pubmed: 80682
Kimura, J. Electrodiagnosis in Deseases of Nerve and Muscle: Principles and Practice 2nd edn. (F.A. Davis, 1989).
Rajabally, Y. A., Durand, M. C., Mitchell, J., Orlikowski, D. & Nicolas, G. Electrophysiological diagnosis of Guillain-Barre syndrome subtype: Could a single study suffice?. J. Neurol. Neurosurg. Psychiatry 86, 115–119. https://doi.org/10.1136/jnnp-2014-307815 (2015).
doi: 10.1136/jnnp-2014-307815
pubmed: 24816419
Rajabally, Y. A. & Uncini, A. Outcome and its predictors in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 83, 711–718. https://doi.org/10.1136/jnnp-2011-301882 (2012).
doi: 10.1136/jnnp-2011-301882
pubmed: 22566597
Walgaard, C. et al. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology 76, 968–975. https://doi.org/10.1212/WNL.0b013e3182104407 (2011).
doi: 10.1212/WNL.0b013e3182104407
pubmed: 21403108
pmcid: 3059137
Khedr, E. M., Mahmoud, D. M., Ahmed, G. K. & Haridy, N. A. Predictors of long-term health-related quality of life in Guillain-Barre syndrome: A hospital-based study. Clin. Neurol. Neurosurg. 235, 108026. https://doi.org/10.1016/j.clineuro.2023.108026 (2023).
doi: 10.1016/j.clineuro.2023.108026
pubmed: 37913589
Hughes, R. A. et al. Supportive care for patients with Guillain-Barre syndrome. Arch. Neurol. 62, 1194–1198. https://doi.org/10.1001/archneur.62.8.1194 (2005).
doi: 10.1001/archneur.62.8.1194
pubmed: 16087757
Netto, A. B. et al. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J. Neurosci. Rural Pract. 8, 68–73. https://doi.org/10.4103/0976-3147.193542 (2017).
doi: 10.4103/0976-3147.193542
pubmed: 28149085
pmcid: 5225726
Lenhard, T., Grimm, C. & Ringleb, P. A. Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 82, 1051–1053. https://doi.org/10.1136/jnnp.2009.192369 (2011).
doi: 10.1136/jnnp.2009.192369
pubmed: 20732865
Kumar, M., Kalita, J. & Misra, U. K. Renal salt wasting in Guillain-Barre syndrome. Postgrad. Med. J. 95, 628–629. https://doi.org/10.1136/postgradmedj-2019-136870 (2019).
doi: 10.1136/postgradmedj-2019-136870
pubmed: 31375556
Zaeem, Z., Siddiqi, Z. A. & Zochodne, D. W. Autonomic involvement in Guillain-Barre syndrome: An update. Clin. Auton. Res. 29, 289–299. https://doi.org/10.1007/s10286-018-0542-y (2019).
doi: 10.1007/s10286-018-0542-y
pubmed: 30019292
Lichtenfeld, P. Autonomic dysfunction in the Guillain-Barre syndrome. Am. J. Med. 50, 772–780. https://doi.org/10.1016/0002-9343(71)90185-9 (1971).
doi: 10.1016/0002-9343(71)90185-9
pubmed: 5089852
Singh, N. K., Jaiswal, A. K., Misra, S. & Srivastava, P. K. Assessment of autonomic dysfunction in Guillain-Barre syndrome and its prognostic implications. Acta Neurol. Scand. 75, 101–105. https://doi.org/10.1111/j.1600-0404.1987.tb07902.x (1987).
doi: 10.1111/j.1600-0404.1987.tb07902.x
pubmed: 3577674
Zochodne, D. W. Autonomic involvement in Guillain-Barre syndrome: A review. Muscle Nerve 17, 1145–1155. https://doi.org/10.1002/mus.880171004 (1994).
doi: 10.1002/mus.880171004
pubmed: 7935521
Colls, B. M. Guillain-Barre syndrome and hyponatraemia. Intern. Med. J. 33, 5–9. https://doi.org/10.1046/j.1445-5994.2002.00322.x (2003).
doi: 10.1046/j.1445-5994.2002.00322.x
pubmed: 12534871
Cui, H. et al. Inappropriate antidiuretic hormone secretion and cerebral salt-wasting syndromes in neurological patients. Front. Neurosci. 13, 1170. https://doi.org/10.3389/fnins.2019.01170 (2019).
doi: 10.3389/fnins.2019.01170
pubmed: 31780881
pmcid: 6857451
Posner, J. B., Ertel, N. H., Kossmann, R. J. & Scheinberg, L. C. Hyponatremia in acute polyneuropathy. Four cases with the syndrome of inappropriate secretion of antidiuretic hormone. Arch. Neurol. 17, 530–541. https://doi.org/10.1001/archneur.1967.00470290084011 (1967).
doi: 10.1001/archneur.1967.00470290084011
pubmed: 4293349
Hemmer, M., Viquerat, C. E., Suter, P. M. & Vallotton, M. B. Urinary antidiuretic hormone excretion during mechanical ventilation and weaning in man. Anesthesiology 52, 395–400. https://doi.org/10.1097/00000542-198005000-00004 (1980).
doi: 10.1097/00000542-198005000-00004
pubmed: 7377572